title: From cannabis to the endocannabinoid system: refocussing attention on potential clinical benefits.
abstract: Cannabis sativa is one of the oldest herbal remedies known to man. Over the past four thousand years, it has been used for the treatment of numerous diseases but due to its psychoactive properties, its current medicinal usage is highly restricted. In this review, we seek to highlight advances made over the last forty years in the understanding of the mechanisms responsible for the effects of cannabis on the human body and how these can potentially be utilized in clinical practice. During this time, the primary active ingredients in cannabis have been isolated, specific cannabinoid receptors have been discovered and at least five endogenous cannabinoid neurotransmitters (endocannabinoids) have been identified. Together, these form the framework of a complex endocannabinoid signalling system that has widespread distribution in the body and plays a role in regulating numerous physiological processes within the body. Cannabinoid ligands are therefore thought to display considerable therapeutic potential and the drive to develop compounds that can be targeted to specific neuronal systems at low enough doses so as to eliminate cognitive side effects remains the 'holy grail' of endocannabinoid research.
authors.affiliation: Department of Preclinical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago. farid.youssef@sta.uwi.edu
authors.forename: F F
authors.initials: FF
authors.lastname: Youssef
authors.forename: A J
authors.initials: AJ
authors.lastname: Irving
mesh_terms: D000818:Animals; D002186:Cannabinoids / Q000494:pharmacology / Q000627:therapeutic use*; D002188:Cannabis; D063388:Endocannabinoids / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans
chemical_list: D002186:Cannabinoids; D063388:Endocannabinoids